IonQ vs. Rigetti vs. D-Wave vs. QUBT: Which Pure-Play Quantum Stock Is the Smartest Bet?
Tech Approach: Rigetti uses superconducting qubits, like Google and IBM (IBM). It recently released a new 84-qubit chip (Ankaa-3) with 99.0% median iSWAP gate fidelity and 99.5% median fidelity for ...
Riot Platforms (RIOT) Expands into High-Performance Computing Amid AI Surge!
We recently published a list of Top 9 AI Ratings and News Updates on Wall Street’s Radar. In this article, we are going to ...
Analysts Offer Insights on Materials Companies: New Found Gold (NFGC) and Lithium Americas Corp. (LAC)
Analysts have been eager to weigh in on the Materials sector with new ratings on New Found Gold (NFGC – Research Report) and Lithium Americas ...
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Week
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes ...
Gain Therapeutics’ (GANX) Buy Rating Reiterated at Chardan Capital
Chardan Capital restated their buy rating on shares of Gain Therapeutics (NASDAQ:GANX – Free Report) in a report published on ...
Roth Capital Has Negative Forecast for ALUR Q1 Earnings
Research analysts at Roth Capital cut their Q1 2025 earnings per share (EPS) estimates for Allurion Technologies in a report released on Wednesday, March 26th. Roth Capital analyst J. Wittes now ...
Bio-Path price target lowered to $9 from $12 at Roth MKM
Roth MKM lowered the firm’s price target on Bio-Path (BPTH) to $9 from $12 and keeps a Buy rating on the shares. The company ended Q4 with ...